Ternalys Therapeutics, Inc

Ternalys Therapeutics’ SAGUARO Platform provides a simple yet elegant way to simultaneously deliver multiple microRNAs, replenishing cancer cells with microRNAs that are present in normal cells but decreased in cancer cells - and thereby reversing the cancer’s defensive epigenetic changes. We have demonstrated the ability to synergistically enhance existing therapies and, by doing so, potentially alter the outcomes for many intractable cancers.